Oral chemotherapy tablets for treating gastric cancer
A technology for tablets and gastric cancer, which is applied in the field of oral chemotherapy tablets for the treatment of gastric cancer, can solve the problems of easily causing dehydration, cardiotoxicity, hindering popularization and use, and achieves good killing of tumor cells, reducing toxicity, improving hardness and disintegration. performance effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0021] An oral chemotherapy tablet for the treatment of gastric cancer, consisting of the following components: capecitabine 58.6mg, cisplatin liposome 17.9mg, oteracil potassium 20.4mg, hydrous lactose 4.6mg, magnesium stearate 2.8mg , Microcrystalline cellulose 3.3mg, pregelatinized starch 4.2mg, starch 38.2mg.
Embodiment 2
[0023] An oral chemotherapy tablet for the treatment of gastric cancer, consisting of the following components: 55 mg capecitabine, 19.5 mg cisplatin liposome, 16.2 mg oteracil potassium, 35.2 mg aqueous lactose, 2.5 mg magnesium stearate, Microcrystalline cellulose 4.2mg, pregelatinized starch 3.7mg, starch 13.7mg.
Embodiment 3
[0025] An oral chemotherapy tablet for treating gastric cancer, consisting of the following components: 79 mg capecitabine, 15.8 mg cisplatin liposome, 22.4 mg oteracil potassium, 3.4 mg aqueous lactose, 3.6 mg magnesium stearate, Microcrystalline cellulose 2.8mg, pregelatinized starch 4.6mg, starch 18.4mg.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com